CL2008003095A1 - Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario. - Google Patents

Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario.

Info

Publication number
CL2008003095A1
CL2008003095A1 CL2008003095A CL2008003095A CL2008003095A1 CL 2008003095 A1 CL2008003095 A1 CL 2008003095A1 CL 2008003095 A CL2008003095 A CL 2008003095A CL 2008003095 A CL2008003095 A CL 2008003095A CL 2008003095 A1 CL2008003095 A1 CL 2008003095A1
Authority
CL
Chile
Prior art keywords
preparation
dihydrothienopyrimides
procedure
compounds considered
intermediate compound
Prior art date
Application number
CL2008003095A
Other languages
English (en)
Inventor
Rogelio Frutos
Dhileepkumar Krishnamurthy
Jason Mulder
Sonia Rodriguez
Chris Hugh Senanayake
Thomas G Tampone
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40158557&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003095(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2008003095A1 publication Critical patent/CL2008003095A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Método para preparar compuestos derivados de dihidrotienopirimidina y los intermediarios utilizados en el proceso.
CL2008003095A 2007-10-18 2008-10-17 Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario. CL2008003095A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98110507P 2007-10-18 2007-10-18

Publications (1)

Publication Number Publication Date
CL2008003095A1 true CL2008003095A1 (es) 2010-01-22

Family

ID=40158557

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2008003095A CL2008003095A1 (es) 2007-10-18 2008-10-17 Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario.
CL2012000560A CL2012000560A1 (es) 2007-10-18 2012-03-01 Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2012000560A CL2012000560A1 (es) 2007-10-18 2012-03-01 Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).

Country Status (20)

Country Link
US (1) US8653282B2 (es)
EP (1) EP2205608B1 (es)
JP (1) JP5538231B2 (es)
KR (1) KR20100095528A (es)
CN (2) CN103497201A (es)
AR (1) AR069077A1 (es)
AU (1) AU2008312624B2 (es)
BR (1) BRPI0818671A2 (es)
CA (1) CA2702500A1 (es)
CL (2) CL2008003095A1 (es)
DK (1) DK2205608T3 (es)
ES (1) ES2424445T3 (es)
IL (1) IL204854A0 (es)
MX (1) MX2010003826A (es)
NZ (2) NZ592534A (es)
PL (1) PL2205608T3 (es)
RU (1) RU2528340C2 (es)
TW (1) TW200918541A (es)
WO (1) WO2009052138A1 (es)
ZA (1) ZA201002425B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP2474523B1 (en) 2006-12-26 2020-04-08 Lantheus Medical Imaging, Inc. Ligands for imaging cardiac innervation
CA2702524A1 (en) 2007-10-19 2009-04-23 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
CN104069112A (zh) 2007-10-19 2014-10-01 贝林格尔.英格海姆国际有限公司 取代的哌啶子基-二氢噻吩并嘧啶
CA2702518A1 (en) 2007-10-19 2009-04-23 Boehringer Ingelheim International Gmbh New piperazino-dihydrothienopyrimidine derivatives
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9840517B2 (en) * 2013-09-18 2017-12-12 Beijing Hanmi Pharmaceutical Co., Ltd. Compound inhibiting activities of BTK and/or JAK3 kinases
KR20250046278A (ko) * 2022-08-09 2025-04-02 시젱 하이스코 파마수티칼 씨오., 엘티디. Pde4b 억제제 및 이의 용도
JP2025534418A (ja) 2022-09-29 2025-10-15 蘇州愛科百発生物医薬技術有限公司 含窒素縮合複素環化合物、その調製方法、および医薬におけるその使用
CU20250021A7 (es) * 2023-02-28 2026-03-10 Innovstone Therapeutics Ltd Compuesto inhibidor de la pde4b,útil para el tratamiento de enfermedades mediadas por pde4b
CN116925099B (zh) * 2023-07-21 2025-06-03 厦门大学 手性二氢噻吩并嘧啶亚砜的制备方法及其应用与其2、4位取代化合物
WO2025162289A2 (zh) * 2024-02-04 2025-08-07 西藏海思科制药有限公司 一种pde4b抑制剂的晶型及其在医药上的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470336A1 (de) * 1962-07-04 1969-03-20 Thomae Gmbh Dr K Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
CH632755A5 (de) * 1976-04-10 1982-10-29 Basf Ag Verfahren zur herstellung von thiophenverbindungen.
DE2700215A1 (de) * 1977-01-05 1978-07-13 Basf Ag Thiophenverbindungen und verfahren zur herstellung von thiophenverbindungen
US4974609A (en) * 1986-08-18 1990-12-04 Philip Morris Incorporated Tobacco flavorants
JP3398152B2 (ja) 1993-10-12 2003-04-21 ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー １ｎ−アルキル−ｎ−アリールピリミジンアミンおよびその誘導体
DE19540737A1 (de) * 1995-11-02 1997-05-07 Bayer Ag Substituierte Sulfonylamino(thio)carbonylverbindungen
WO1999024440A1 (en) * 1997-11-11 1999-05-20 Pfizer Products Inc. Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
CN101163706A (zh) 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
ES2383249T3 (es) 2007-09-25 2012-06-19 Actimis Pharmaceuticals, Inc. Alquiltiopirimidinas como antagonistas de CRTH2
CN104069112A (zh) 2007-10-19 2014-10-01 贝林格尔.英格海姆国际有限公司 取代的哌啶子基-二氢噻吩并嘧啶
CA2702524A1 (en) * 2007-10-19 2009-04-23 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines

Also Published As

Publication number Publication date
CL2012000560A1 (es) 2012-09-14
DK2205608T3 (da) 2013-07-01
EP2205608A1 (en) 2010-07-14
NZ592534A (en) 2013-03-28
TW200918541A (en) 2009-05-01
CN103497201A (zh) 2014-01-08
ZA201002425B (en) 2011-02-23
JP5538231B2 (ja) 2014-07-02
BRPI0818671A2 (pt) 2015-09-15
WO2009052138A1 (en) 2009-04-23
AU2008312624B2 (en) 2014-07-10
EP2205608B1 (en) 2013-05-08
CN101903394A (zh) 2010-12-01
IL204854A0 (en) 2010-11-30
RU2010119647A (ru) 2011-11-27
KR20100095528A (ko) 2010-08-31
CN101903394B (zh) 2013-12-25
WO2009052138A8 (en) 2012-11-15
ES2424445T3 (es) 2013-10-02
US8653282B2 (en) 2014-02-18
NZ584962A (en) 2011-07-29
JP2011500701A (ja) 2011-01-06
AU2008312624A1 (en) 2009-04-23
US20100222585A1 (en) 2010-09-02
MX2010003826A (es) 2010-04-21
PL2205608T3 (pl) 2013-09-30
CA2702500A1 (en) 2009-04-23
AR069077A1 (es) 2009-12-30
RU2528340C2 (ru) 2014-09-10

Similar Documents

Publication Publication Date Title
UY32049A (es) Inhibidores de cmet
DK2346888T3 (da) Fremgangsmåde til fremstilling af som SGLT-inhibitorer anvendelige forbindelser
MX2012012527A (es) Compuestos quimicos.
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
CR11776A (es) Inhibidores de bace
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
EA201391313A1 (ru) C4-монометилтритерпеноидные производные и способы их применения
UY32863A (es) COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR
ECSP10010722A (es) Compuestos orgánicos
CR20120334A (es) Derivados de imidazopiridina como inhibidores de jak
CR20120295A (es) Triazolopiridinas
SV2016005149A (es) Polimorfo de los inhibidores de la syk
EA201270149A1 (ru) Ингибиторы bace
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
UY34365A (es) Compuestos heterociclicos
CR20140275A (es) Triazolopiridinas sustituidas
CU20130044A7 (es) Proceso para la preparación de inhibidores de pan-cdk de fórmula (i), e intermediarios de la preparación
CL2012000278A1 (es) Proceso para la obtencion de derivados de 5-trifluorometil-pirimidinas; y uno de los compuestos intermediarios considerados.
UY32077A (es) Inhibidores de quinasa tipo polo
EA200900945A1 (ru) Новый способ синтеза агомелатина
CR20120635A (es) Compuestos heterocìclicos de nitrògeno ùtiles como inhibidores de pde10
CL2009001686A1 (es) Procedimiento de preparacion de agomelatina; y los compuestos intermediarios considerados.
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
EA200900943A1 (ru) Новый способ синтеза агомелатина